Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon R Greenberg

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|March 27, 2003
A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel diseaseMark S Silverberg, Lucia Mirea, Shelley B Bull, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Ileal pouch symptoms do not correlate with inflammation of the pouchOfer Ben-Bassat, Andrea D Tyler, Wei Xu, et al.
Gastroenterology|July 10, 2002
Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trialA Hillary Steinhart, Brian G Feagan, Cindy J Wong, et al.
Inflammatory Bowel Diseases|July 16, 2015
Predictors of Outcome in Ulcerative ColitisMatti Waterman, Jo Knight, Amreen Dinani, et al.
The American Journal of Gastroenterology|March 30, 2004
CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's diseaseBill Newman, Mark S Silverberg, Xiangjun Gu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2008
Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrinBrian G Feagan, Gordon R Greenberg, Gary Wild, et al.
Inflammatory Bowel Diseases|September 9, 2016
Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal AnastomosisEran Zittan, Raquel Milgrom, Grace W Ma, et al.
The New England Journal of Medicine|June 17, 2005
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrinBrian G Feagan, Gordon R Greenberg, Gary Wild, et al.
Gut|October 23, 2014
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's diseaseNiels Vande Casteele, Reena Khanna, Barrett G Levesque, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|March 27, 2003
A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel diseaseMark S Silverberg, Lucia Mirea, Shelley B Bull, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 1, 2013
Ileal pouch symptoms do not correlate with inflammation of the pouchOfer Ben-Bassat, Andrea D Tyler, Wei Xu, et al.
Gastroenterology|July 10, 2002
Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trialA Hillary Steinhart, Brian G Feagan, Cindy J Wong, et al.
Inflammatory Bowel Diseases|July 16, 2015
Predictors of Outcome in Ulcerative ColitisMatti Waterman, Jo Knight, Amreen Dinani, et al.
The American Journal of Gastroenterology|March 30, 2004
CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's diseaseBill Newman, Mark S Silverberg, Xiangjun Gu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2008
Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrinBrian G Feagan, Gordon R Greenberg, Gary Wild, et al.
Inflammatory Bowel Diseases|September 9, 2016
Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal AnastomosisEran Zittan, Raquel Milgrom, Grace W Ma, et al.
The New England Journal of Medicine|June 17, 2005
Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrinBrian G Feagan, Gordon R Greenberg, Gary Wild, et al.
Gut|October 23, 2014
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's diseaseNiels Vande Casteele, Reena Khanna, Barrett G Levesque, et al.
Lancet (London, England)|September 7, 2015
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trialReena Khanna, Brian Bressler, Barrett G Levesque, et al.
Pageof 4